Cegedim is advancing 2% after presenting sales growth of 5.9% to €555.6 million (+5.1% organic) for the full year 2022, including an increase of 4.1% to €154.7 million (+2.9% organic) in the fourth quarter alone.

"This moderate growth in the final quarter stems essentially from December 2022, which saw sales increase by 0.4% compared with December 2021, the lowest monthly growth rate of the year", the company states.

The launch of Cegedim Santé's development plan and lower sales in the UK will have a negative impact on operating income recurring in 2022. Cegedim anticipates sales growth in 2023 in the 6% to 9% range.

Copyright (c) 2023 CercleFinance.com. All rights reserved.